Transforming Discovery into Opportunity

CDRD Immunotherapy Symposium



2017-05-26


CDRD, Canada’s national drug development and commercialization engine, is hosting a symposium “Immunotherapy: Novel platforms and strategies advancing cancer research.”

Join us and top oncology researchers from across Canada to learn about recent advances in immunotherapy, outcomes, lessons learned and where we are headed.

The full day session includes short and concise talks, a moderated panel discussion, brainstorming sessions and opportunities to networks and explore potential partnerships and collaborations.

This event is free of charge but pre-registration is required: https://cdrd-immunotherapy.eventbrite.ca.

 

Draft agenda

8:30 – 8:50am: Continental breakfast

8:45 – 9:00am: Welcoming remarks and brief overview of CDRD’s Immunotherapy Initiative

9:00 – 9:40am: “The power of the fish for immunotherapy research” – Dr. Jason Berman (MSC Clinician Scientist in Pediatric Oncology, IWK Health Centre)

9:40 – 10:00am: Dr. Brad Nelson (Director and Distinguished Scientist, Deeley Research Centre, BC Cancer Agency)

10:00 – 10:20am: Dr. Rebecca Auer (Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute)

10:20 – 10:50am: Coffee break and networking

10:50 – 11:10am: Dr. Carl Hansen (CEO & President, Co-Founder, AbCellera)

11:10 – 11:30am: Dr. Rob Holt (Head of Sequencing, Michael Smith Genome Sciences Centre, and Distinguished Scientist, BC Cancer Agency)

11:30 – 11:50am: Dr. Thomas Kislinger (Senior Scientist, Princess Margaret Cancer Centre)

11:50am – 12:50pm: Moderated Panel Discussion, Q&A session

12:50 – 1:50pm: Networking lunch

Sign up to our newsletter

Receive CDRD's e-newsletter, The CDRD Pipeline and other e-communications for regular updates on all our news and activities.



© Copyright 2017 CDRD. All rights reserved.

>